GE HealthCare Technologies Inc. reported a 3% increase in revenues, reaching $4.8 billion for the first quarter of 2025, with organic revenue growth at 4%. The company's net income attributable to GE HealthCare rose to $564 million, up from $374 million in the previous year, resulting in a net income margin of 11.8%, compared to 8.0% from the prior year. Adjusted earnings before interest and taxes $(EBIT)$ was reported at $715 million, an increase from $681 million, with an adjusted EBIT margin of 15.0%, up from 14.7%. Diluted earnings per share $(EPS)$ improved to $1.23 from $0.81 the previous year, while adjusted EPS increased to $1.01 from $0.90. The company noted strong order growth, with organic orders increasing by a record 10% year-over-year, and a total company book-to-bill ratio of 1.09 times. GE HealthCare's cash flow from operating activities was $250 million, down from $419 million, with free cash flow at $98 million compared to $274 million the previous year. Additionally, the Board of Directors authorized a $1 billion share repurchase program as part of the company's strategic financial initiatives.